4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-24-022363
SVP, CHIEF TECHNICAL OFFICER acquired 5,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-27 | Option exercise | +5,580 | $18.41 | $102,728 | 173,756 | D |
| Derivatives | |||||||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2024-08-27 | Option exercise · Option to Purchase Common Stock | −5,580 | 0 | D | ||
Loading xslF345X05/form4-08272024_110848.xml…